The trading price of BioAffinity Technologies Inc (NASDAQ:BIAF) closed higher on Tuesday, May 27, and closing at $0.27, 4.01% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $2.99 and a 52-week low of $0.16. Over the past month, the stock has lost -45.41% in value.
BioAffinity Technologies Inc, whose market valuation is $7.59 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest BIAF has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that BIAF’s price is currently -4.77% off the SMA20 and -32.37% off the SMA50. The RSI metric on the 14-day chart is currently showing 42.89, and weekly volatility stands at 3.91%. When measured over the past 30 days, the indicator reaches 15.65%. BioAffinity Technologies Inc (NASDAQ:BIAF)’s beta value is currently sitting at 2.76, while the Average True Range indicator is currently displaying 0.06.
To see how BioAffinity Technologies Inc stock has been performing in comparison to its peers in the industry, here are the numbers: BIAF stock’s performance was 4.01% in the latest trading, and -89.02% in the past year.
An evaluation of the daily trading volume of BioAffinity Technologies Inc (NASDAQ:BIAF) indicates that the 3-month average is 11.26 million.
Currently, records show that 27.25 million of the company’s shares remain outstanding. The insiders hold 28.84% of outstanding shares, whereas institutions hold 1.88%. However, since the stock’s price has seen -70.07% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
